Integrating homeopathic care into a comprehensive cancer center
Official title: Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
Run by Rambam Health Care Campus · NCT05833165 · Data updated 2026-11-12
This project will try offering homeopathic consultations to adult cancer patients at Rambam to see if patients accept and can use this approach as part of supportive care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Rambam Health Care Campus Academic / other |
| Locations | 1 site (Haifa) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT05833165 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) treated in the Division of Oncology at Rambam who read and understand Hebrew, have ECOG performance status 0–2, and consent to participate are ideal candidates.
✕Probably not a fit
Patients with active psychosis, severe cognitive impairment, frailty or ECOG >2, or other unstable acute medical conditions are unlikely to benefit or be eligible to participate.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational feasibility project at Rambam Health Campus that offers homeopathic consultations within the existing complementary and integrative oncology service. Adult oncology patients who meet eligibility criteria will be invited to a detailed homeopathic interview and follow-up, and investigators will record uptake, reasons for choosing the service, completion of visits, and any logistical barriers. The study will collect basic patient-reported information about experience and tolerability but does not test clinical efficacy. Results will focus on acceptability, integration challenges, and practical implementation metrics to inform future work.
Why it matters
Potential benefit: If successful, it could provide an additional supportive care option that some patients find helpful for well‑being and symptom coping.
How similar studies have gone: While integrative oncology services commonly include homeopathy in some countries, high‑quality evidence of clinical benefit in cancer patients is limited, so feasibility work like this remains relatively novel in the Israeli comprehensive cancer center setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • 18 years of age or older * Ability to read, write, and understand the Hebrew language * Patients treated at the Division of Oncology in Rambam Health Campus. * Performance status of ECOG 0-2. * Consent to participate in the study. Exclusion Criteria: * • Inability to understand the intent of the study and follow the instructions * Diagnosis of active psychosis, altered mental state or severe cognitive impairment confirmed by the patient's attending physician. * Frailty, ECOG worse than 2, or other unstable medical conditions as confirmed by the patient's attending physician including acute illness, fever, unclear rash or medical conditions that would preclude participation in an interview session lasting 15-30 minutes
Where it's running
-
Rambam Medical Center
Haifa, Israel Recruiting
Study contacts
- Study coordinator: Moshe Frenkel, MD
- Email: frenkelm@netvision.net.il
- Phone: 972523311255
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual meaning-centered group therapy for adults with a history of cancer
This program will test whether a virtual meaning-centered group therapy helps adults with a history of cancer reduce anxiety and depression and improve quality of life and sense of meaning.
-
Calcium Gluconate After Birth to Reduce Blood Loss in Vaginal Delivery
This study tests whether giving calcium gluconate right after the baby is born can help reduce blood loss for people having a vaginal delivery.
-
Cervical ripening balloon left in place for 3 hours vs 12 hours during labor induction
This study tests whether keeping the cervical ripening balloon in for 3 hours works as well as the standard 12 hours to shorten time to delivery in pregnant people induced for labor.
-
Metamizole (Optalgin) impact on anti‑Xa levels in cancer patients on apixaban or rivaroxaban
This study will test whether taking metamizole (Optalgin) changes anti‑Xa blood levels in adults with cancer who are taking apixaban or rivaroxaban.
-
Y‑incision versus standard aortic root enlargement for people with a small aortic annulus
This compares the Y‑incision versus standard surgical enlargement to see if surgeons can implant larger valves and reduce patient‑prosthesis mismatch in adults needing aortic valve replacement who have a small aortic annulus.
-
Exploring how gut bacteria affect cannabis oil treatment in fibromyalgia patients
This study is testing how gut bacteria might affect how well cannabis oil works for people with fibromyalgia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.